ATOS

Atossa Therapeutics Inc.

Price

$2.52

return (12m)

-77.72%

p/e

-0.63

p/bv

0.89

DIVIDEND YIELD

0.00%

ATOS price

Atossa Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ATOS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.25%

3 months

-51.82%

1 year

-77.72%

2 years

-87.83%

5 years

-95.24%

10 years

-99.44%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ATOS

Valuation

P/E

-0.63

Sector -4.26

Industry -4.26

P/BV

0.89

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

0.74

Sector 1.25

Industry 1.25

P/Net Current Assets

0.93

Sector -5.47

Industry -5.47

P/Working Capital

0.93

Sector -1.10

Industry -1.10

EPS

-4.19

Sector -1.94

Industry -1.94

BVPS

2.98

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-140.55%

Sector -61.50%

Industry -61.50%

ROA

-116.82%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.69

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.83

Sector 0.43

Industry 0.43

Liabilities/Assets

0.17

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

12.84%

Sector -

Industry -

Fundamentals ATOS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ATOS Atossa Therapeutics Inc.	$2.52	-77.94%	0.00%	-0.63	0.89	-140.55%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ATOS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Atossa Therapeutics

Atossa Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

17 years

Founded: 2009

2012

Time since IPO - 14 years

8

Employees

Atossa Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $23.76 million, with shareholders equity totaling $26.83 million.

The company employs approximately 8 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Atossa Therapeutics Inc. reported $- in revenue, generating net income of $-37.71 million.

Key financial metrics include a P/E ratio of -0.63, a price-to-book (P/B) ratio of 0.89, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ATOS.

Market cap

$23.76 million

Net worth

$26.83 million

$26,830,000.00

Assets

$32.28 million

$32,280,000.00

Total Shares Outstanding

9.00 million

9,000,000

Average Daily Trading Volume

$144.16 Thousand

$144,158.92

Sector

Health Care

Industry

Biotechnology

ATOS

ATOS revenue and profits

Financial Results ATOS

DRAG THE FRAME TO SEE MORE DATA

ATOS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Atossa Therapeutics (ATOS) today?

A cotação de Atossa Therapeutics (ATOS) hoje está em US$ 2.52, com uma variação de -77.72% em relação ao último ano. A cotação de Atossa Therapeutics (ATOS) iniciou o ano negociando na casa dos US$ 0.59 e hoje está em US$ 2.52. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Atossa Therapeutics (ATOS) e dados de ações do Ibovespa e mercados internacionais.

Quando Atossa Therapeutics (ATOS) paga dividendos?

Atossa Therapeutics (ATOS) não distribuiu dividendos no último ano.

Is Atossa Therapeutics (ATOS) a good investment?

Atualmente, Atossa Therapeutics (ATOS) está cotada a US$ 2.52, com um P/L de -0.63, representando um desvio de -3,359% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -77.72 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -77.72%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Atossa Therapeutics (ATOS) stock?

Investir em ações de Atossa Therapeutics (ATOS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Atossa Therapeutics (ATOS) yield today?

A rentabilidade de Atossa Therapeutics (ATOS) foi de 12.25% no último mês, -77.72% no último ano e -95.24% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Atossa Therapeutics (ATOS) hoje, o investimento total seria de US$ 252.00, com base na cotação atual de US$ 2.52.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 56.15
Em 5 anos: US$ 12.00
Em 10 anos: US$ 1.41

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ATOS

Atossa Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ATOS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ATOS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Atossa Therapeutics

Atossa Therapeutics Inc.

United States

17 years

2012

8

PROFIT X PRICE ATOS

Financial Results ATOS

ATOS cash flow

Asset, Revenue and Profit Growth - ATOS

ATOS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions